講演情報
[P2-20]ゲムシタビンと WT1₁₂₆ ペプチドワクチンの併用療法を受けた膵癌患者からの新規高アビディティ TCR の単離
Isolation of a novel high-avidity TCR in pancreatic cancer patients treated with the combination of gemcitabine and WT1126 peptide vaccine
*Soyoko Morimoto1,3, Sumiyuki Nishida2,3, Fumihiro Fujiki4, Atsushi Kumanogoh2,3, Haruo Sugiyama5 (1. Department of Cancer Stem Cell Biology, Graduate School of Medicine, The University of Osaka (Japan), 2. Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka (Japan), 3. Center for Advanced Modalities and Drug Delivery System, The University of Osaka (Japan), 4. Department of Cancer Immunotherapy, Graduate School of Medicine, The University of Osaka (Japan), 5. Department of Cancer Immunology, Graduate School of Medicine, The University of Osaka (Japan))
閲覧にはパスワードが必要です
ログイン
または
コメント
コメントの閲覧・投稿にはログインが必要です。ログイン